Cas:911819-08-4 Ophiopojaponin C manufacturer & supplier

We serve Chemical Name:Ophiopojaponin C CAS:911819-08-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ophiopojaponin C

Chemical Name:Ophiopojaponin C
CAS.NO:911819-08-4
Synonyms:Desacetylophiopogonin B’;(3β,25R)-14,17-Dihydroxyspirost-5-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[β-D-xylopyranosyl-(1->4)]-β-D-glucopyranoside;ophiopojaponin C;β-D-Glucopyranoside, (3β,25R)-14,17-dihydroxyspirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[β-D-xylopyranosyl-(1->4)]-;Ophiopogonin D’;ophiopojagonin C
Molecular Formula:C44H70O18
Molecular Weight:887.016
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.5±0.1 g/cm3
Index of Refraction:1.638
PSA:276.14000
Exact Mass:886.456238
LogP:4.77

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Desacetylophiopogonin B’ chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ophiopojagonin C physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ophiopogonin D’ Use and application,Desacetylophiopogonin B’ technical grade,usp/ep/jp grade.


Related News: South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days. Ophiopojaponin C manufacturer Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. Ophiopojaponin C supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. Ophiopojaponin C vendor Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. Ophiopojaponin C factory South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days.